Wilson et al. reported similar co-occurring gene pair mutations among breast cancer subtypes (HER2+, hormone receptor positive [HR+], and triple-negative breast cancer [TNBC]) [49]. Here, ERBB2 is linked to triple-negative breast carcinoma.